Comparative study of the use of poly(glycolic acid), calcium alginate and pluronics in the engineering of autologous porcine cartilage.
New cartilage formation has been successfully achieved by technology referred to as tissue engineering. Polymers and hydrogels such as poly(glycolic acid), calcium alginate, and poly(ethylene) and poly(propylene) hydrogels have been used as cell carriers to regenerate cartilage in the nude mouse model. The next step toward human applications of engineered cartilage is to demonstrate their potential in immunocompetent animal models. This study compared the suitability of three polymers for generating tissue engineered elastic cartilage using autologous cells in an immuno-competent porcine animal model. Auricular cartilage was obtained from pigs. Chondrocytes were isolated onto fiber based poly(glycolic acid) (PGA) scaffolds or suspended in calcium alginate or pluronic F127 gel at constant concentrations. Chondrocyte-polymer constructs were either implanted (PGA) or injected (calcium alginate and pluronic) as autologous implants subcutaneously into the pigs from which the cells had been isolated. Specimens were harvested and analyzed grossly and historically after 6 weeks in vivo. All explants demonstrated cartilage formation to a variable degree. When using PGA or calcium alginate, the overall histological appearance of the tissue formed is that of fibrocartilage with thick bundles of collagen dispersed in the tissue. When using pluronics as scaffold, histologic features resemble those of native elastic cartilage, showing a more organized arrangement of the cells, which seems to correlate to functional properties as elastin presence in the tissue engineered cartilage. Elastic cartilage engineered in an immunocompetent animal model varies with the type of polymer used. The behavior of the cell-polymer constructs is not fully understood and outcome seems to be related to several factors, including inflammatory reaction. Further studies with similar models are needed to determine the feasibility of engineering tissue generated from different cell-polymer constructs prior to human application.
Cao
Y
Y
Department of Anesthesia, University of Massachusetts Medical Center, Worcester 01655, USA.
Rodriguez
A
A
Vacanti
M
M
Ibarra
C
C
Arevalo
C
C
Vacanti
C A
CA
D000464:Alginates; D000818:Animals; D001672:Biocompatible Materials; D002469:Cell Separation; D017690:Cell Transplantation; D019902:Chondrocytes / Q000637:transplantation; D004425:Ear Cartilage / Q000166:cytology*; D005782:Gels; D020723:Glucuronic Acid; D006603:Hexuronic Acids; D008297:Male; D011092:Polyethylene Glycols; D011100:Polyglycolic Acid; D011108:Polymers; D011409:Propylene Glycols; D013552:Swine; D014182:Transplantation, Autologous
D000464:Alginates; D001672:Biocompatible Materials; D005782:Gels; D006603:Hexuronic Acids; D011108:Polymers; D011409:Propylene Glycols; C012504:polypropylene glycol; D011100:Polyglycolic Acid; D011092:Polyethylene Glycols; D020723:Glucuronic Acid